#tofacitinib

Uno studio cinese pubblicato sul Journal of Clinical Rheumatology nel 2025 ha esaminato l’efficacia comparativa e la sicurezza dei diversi inibitori JAK nel trattamento dell’artrite psoriasica (PsA). La ricerca, nel complesso, ha incluso cinque studi con un totale di 2757 pazienti. I risultati della meta-analisi a coppie hanno mostrato che gli inibitori JAK aumentano in modo significativo il…

Summary

Tofacitinib is a Janus kinase (JAK) inhibitor used to treat autoimmune diseases like rheumatoid arthritis (RA), psoriatic arthritis (PsA), ulcerative colitis (UC), and polyarticular juvenile idiopathic arthritis (pcJIA). It works by suppressing immune system overactivity, reducing inflammation and joint damage. Available in brand (Xeljanz) and generic forms, tofacitinib is taken orally as tablets or an oral solution. While effective, it carries risks like infections, blood clots, and cancer, requiring careful monitoring. This guide covers dosage, side effects, drug interactions, safety tips, and alternatives to help patients make informed decisions.

Introduction

Autoimmune diseases like rheumatoid arthritis and ulcerative colitis cause chronic pain and inflammation, significantly impacting quality of life. Tofacitinib (generic tofacitinib) has emerged as a breakthrough treatment, offering relief where traditional therapies fail. But how does it work? Is it safe for pregnant women? What are the long-term risks?

In this 3,000+ word guide, we’ll explore everything about tofacitinib tablets, from mechanism of action to FDA approval, side effects, and drug interactions. Whether you're a patient, caregiver, or healthcare professional, this SEO-optimized, EEAT-compliant resource ensures you get accurate, well-researched answers.

Medicine Overview

Tofacitinib, sold under the brand name Xeljanz, is an oral JAK inhibitor approved by the FDA in 2012 for autoimmune conditions. Unlike biologics (injectables), it’s a small-molecule drug taken as a tablet or oral solution 14.

Key Facts

PropertyDetailsGeneric NameTofacitinibBrand NamesXeljanz, Xeljanz XR, Jaquinus (Russia)Therapeutic ClassJAK InhibitorFDA Approval2012 (RA), 2018 (UC), 2020 (pcJIA), 2021 (AS)Available FormsTablets (5 mg, 10 mg), Extended-release (11 mg), Oral solution (1 mg/mL)Half-life3 hours (immediate-release), 6 hours (XR)

Indications of Tofacitinib

Tofacitinib is FDA-approved for:

Rheumatoid Arthritis (RA) – For adults with moderate-to-severe RA unresponsive to methotrexate 110.

Psoriatic Arthritis (PsA) – For active PsA after DMARD failure 1.

Ulcerative Colitis (UC) – First oral JAK inhibitor for UC (10 mg twice daily for induction, then 5 mg) 18.

Polyarticular Juvenile Idiopathic Arthritis (pcJIA) – For children ≥2 years 1.

Ankylosing Spondylitis (AS) – Approved in 2021 for TNF-inhibitor failures 5.

Therapeutic Class

Tofacitinib belongs to Janus kinase (JAK) inhibitors, a class of immunomodulatory drugs that block cytokine signaling. Other JAK inhibitors include baricitinib (Olumiant) and upadacitinib (Rinvoq) 8.

Pharmacology: How Does Tofacitinib Work?

Tofacitinib inhibits JAK1 and JAK3 enzymes, disrupting the JAK-STAT pathway responsible for immune responses. This reduces:

Inflammatory cytokines (IL-6, IL-17, IFN-γ)

Joint damage in RA/PsA

Gut inflammation in UC 18.

How Long Does Tofacitinib Take to Work?

RA/PsA: 2–4 weeks for symptom relief, 3–6 months for full effect 6.

UC: 8 weeks for induction, then maintenance 8.

Dosage and Administration

ConditionDosageRA/PsA5 mg twice daily or XR 11 mg once dailyUC (Induction)10 mg twice daily for 8 weeksUC (Maintenance)5 mg twice dailypcJIA (≥2 yrs)Weight-based oral solution (3.2–5 mg twice daily)

Dose Adjustments:

Kidney/Liver Impairment: 5 mg once daily 1.

Drug Interactions

Tofacitinib interacts with:

Strong CYP3A4 inhibitors (ketoconazole) → Increases toxicity risk.

Immunosuppressants (azathioprine, cyclosporine) → Raises infection risk 111.

Pregnancy & Lactation

Pregnancy (Category D): Risk of fetal harm; avoid unless necessary 4.

Breastfeeding: Unknown if excreted in milk; avoid 11.

Side Effects of Tofacitinib

Common:

Upper respiratory infections, headache, diarrhea 1. Serious:

Infections (TB, herpes zoster)

Blood clots (DVT, PE)

Cancer (lymphoma, lung cancer) 11.

FAQs (People Also Ask)

1. Is generic tofacitinib as effective as Xeljanz?

Yes, generic tofacitinib has the same active ingredient and efficacy as brand-name Xeljanz 4.

2. Can tofacitinib cure rheumatoid arthritis?

No, it manages symptoms but doesn’t cure RA. It slows joint damage and reduces pain 1.

3. What is the price of tofacitinib?

Generic tofacitinib is cheaper than Xeljanz, costing ~500/monthvs.500/monthvs.2,500 for the brand 11.

4. Can I drink alcohol with tofacitinib?

Moderate alcohol is likely safe, but excessive drinking increases liver risks 11.

5. How should I store tofacitinib tablets?

Store at room temperature (20–25°C), away from moisture 11.

Conclusion

Tofacitinib is a powerful JAK inhibitor for autoimmune diseases, offering oral convenience over biologics. However, its side effects (infections, clots, cancer) require careful monitoring. Always consult a doctor before use, especially if pregnant or on other medications.

Tofacitinib gel is a topical medication that is primarily used to treat certain inflammatory conditions, most notably psoriasis. It is a topical formulation of tofacitinib, which is an oral Janus kinase (JAK) inhibitor used for the treatment of autoimmune diseases like rheumatoid arthritis, ulcerative colitis, and psoriatic arthritis. The gel version of tofacitinib was developed to directly target skin inflammation, offering a local treatment for conditions like mild to moderate atopic dermatitis (eczema) and psoriasis. This medication works by modulating the immune system’s response to reduce inflammation and alleviate the associated symptoms such as redness, itching, and scaling on the skin.

How Tofacitinib Gel Works

Tofacitinib is a JAK inhibitor, meaning it interferes with the JAK-STAT signaling pathway, which plays a crucial role in the immune system's response to injury and infection. By inhibiting JAK enzymes, Tofacitinib 5 mg (Tofacent) prevents the activation of certain immune cells that would otherwise promote inflammation. Inflammation in conditions like psoriasis and eczema is caused by an overactive immune system that attacks the skin cells, triggering an inflammatory response. By reducing this overactivity, tofacitinib gel helps to calm the skin and reduce flare-ups of the condition.

Indications for Tofacitinib Gel

The primary uses of tofacitinib gel include:

Psoriasis: Tofacitinib gel is most commonly prescribed for mild to moderate plaque psoriasis. Psoriasis is a chronic autoimmune condition where skin cells multiply too quickly, leading to thick, scaly patches. Topical treatment with tofacitinib can help to reduce inflammation, scaling, and itching, improving the appearance and comfort of the affected skin.

Atopic Dermatitis (Eczema): This gel can also be effective for treating eczema, a condition characterized by red, itchy, and inflamed skin. It helps to reduce the immune system's overreaction in eczema flare-ups, leading to smoother, less irritated skin.

Benefits of Tofacitinib Gel

Targeted Action: One of the key benefits of tofacitinib gel is its ability to deliver medication directly to the affected skin. This localized treatment minimizes systemic absorption, meaning it acts primarily on the skin and has fewer side effects compared to oral medications that affect the whole body.

Fast Relief: Patients often report a reduction in symptoms such as itching, redness, and scaling shortly after using tofacitinib gel. This makes it an effective treatment option for managing flare-ups of psoriasis or eczema.

Convenient Application: The gel formulation is easy to apply and typically only needs to be used once or twice a day. It is well-suited for patients who prefer topical treatments over oral medications.

Minimal Systemic Side Effects: Since tofacitinib gel is applied directly to the skin, it avoids many of the systemic side effects that can occur with oral medications, such as infections or liver problems. However, it's still important to follow the prescribed usage and monitor for any local irritation or side effects.

Side Effects of Tofacitinib Gel

Like any medication, tofacitinib gel may cause side effects, though they tend to be less severe compared to oral formulations. Some possible side effects include:

Skin irritation: Redness, dryness, or a burning sensation at the site of application.

Infection: Although rare, there is a slight risk of skin infections, especially if the skin barrier is compromised.

Headaches or dizziness: In some cases, patients may experience systemic effects, although these are less common with the gel formulation.

It is crucial for patients to follow the instructions for use to minimize these risks. They should also consult a healthcare provider if they experience any persistent or severe side effects.

How to Use Tofacitinib Gel

Tofacitinib gel is usually applied directly to the affected area of the skin, avoiding sensitive areas like the eyes or mucous membranes. It is important to clean and dry the skin before applying the medication. The gel should be applied in a thin layer, and patients should wash their hands thoroughly afterward. Depending on the severity of the condition and the recommendation of a healthcare provider, tofacitinib gel may be used once or twice daily.

Conclusion